Loading term…
The systematic evaluation of the likelihood that a suspect drug caused or contributed to an adverse event, using clinical judgment and established algorithms.
After reviewing timing, dechallenge, rechallenge, alternative causes, and biological plausibility, the assessor concludes the drug is 'probably' related to the patient's hepatotoxicity.
ICH E2A, WHO-UMC Guidelines
Relying solely on algorithms without clinical judgment, or conversely, making assessments without any structured approach.
Describe your causality assessment methodology. How do you ensure consistency across assessors?